Please login to the form below

Not currently logged in
Email:
Password:

epilepsy

This page shows the latest epilepsy news and features for those working in and with pharma, biotech and healthcare.

It’s only money

It’s only money

anti-epilepsy drug was increased by up to 2, 600%.

Latest news

More from news
Approximately 28 fully matching, plus 177 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 1 fully matching, plus 8 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 4 partially matching documents found.

Latest from PMHub

  • Rare Disease Day 2018: Five things you should know about rare diseases.

    some types of epilepsy are reported to affect about 100 families [9]).

  • How can pharma engage with NHS Vanguards?

    For example, pharma could identify how many people with epilepsy use A&E following a seizure, but the wider vanguard perspective could be to risk stratify why any patients, including those ... with epilepsy, attend A&E.

  • Just::Health Communications

    Having a lively mix of businesses and charities of all sizes, with challenges in everything from asthma to ADHD, epilepsy to oncology, arthritis to sexual health, keeps thinking fresh.

  • Just::Health Communications

    Having a lively mix of businesses and charities of all sizes, with challenges in everything from asthma to ADHD, epilepsy to oncology, arthritis to sexual health, keeps thinking fresh.

  • Life crowned Communications Agency Team of the Year!

    But in order to gain the prestigious title, the Life team competed against nine other agencies in the final, with each team pitching their ideas for a fictitious epilepsy brand. ... On accepting the award it was revealed that Life was singled out by the

More from PMHub
Approximately 0 fully matching, plus 7 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Kendle Healthcare

Company founder Neil Kendle was a pioneer in opinion leader engagement. In 2003, Neil brought together a small, dedicated team...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics